http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3749784-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
filingDate 1972-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1973-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d08270ec2a461921a8df09c8cd54d3e2
publicationDate 1973-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3749784-A
titleOfInvention Psoriasis treatment
abstract PSORIASIS IS TREATED TOPICALLY, PARENTERALLY OF ORALLY WITH VINCALEUCOBLASTINE (VINBLASTINE, VLB) OR LEUROCRISTINE (VINCRISTINE).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4188394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4602909-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4788061-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2521007-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4619935-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2597750-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015073008-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4946833-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4966903-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0041030-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2483235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2531860-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0243278-A1
priorityDate 1972-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12814305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124516887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450207671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504623
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414880224

Total number of triples: 51.